Column: Merck says it was “forced” to negotiate drug prices with Medicare. This is nonsense
No one really expected the pharmaceutical industry to sit back and accept when Congress authorized Medicare to begin negotiating the prices of the prescription drugs it buys for enrollees. By that standard, the federal lawsuit filed on June 6 by major drugmaker Merck falls into the no-news category of man biting dog. So too was … Read more